rawfin.tv
Hoth Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice
RegulationstocksAI Generated

Hoth Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Hoth Therapeutics (HOTH) has received a notice from Nasdaq indicating non-compliance with the minimum $1.00 bid price requirement. This deficiency notice puts the company at risk of delisting if it fails to regain compliance within the stipulated period.

NasdaqComplianceBiotechnologySmall CapDelisting Risk

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks